NCMM is recruiting for a new group leader in Precision Medicine. The role also includes a generous start-up package. Outstanding international candidates are encouraged to apply. Deadline: 15 September
Authors of a paper published in Nature Genetics include several NCMM Associate Investigators, heads of Norwegian EATRIS platforms, and scientists from the Finnish Nordic EMBL Partnership node, FIMM
A prestigious Horizon 2020-MSCA-ITN European Training Network grant has been awarded to a collaboration between a number of research groups and organisations which include the group of NCMM Assistant Director, Hartmut Luecke.
The 2019 NCMM scientific retreat took place at the Sundvolden Hotel on 12-13 June 2019.
The collaborative group, Translation Together, has published an article examining the skillset and qualities that make for a successful translational scientist.
NCMM's annual report for 2018 is now available.
Seed funding allocated to help encourage research collaborations across the wider NCMM network.
Five EATRIS members, including NCMM and the Finnish Nordic EMBL partnership node, FIMM, assist reproducibility study
NCMM Group Leader shared some insight into the mechanisms of the gene editing technique and its uses.
NCMM Associate Investigator, Professor Anne Simonesen, has been named as one of the winners of the King Olav V's Prize for Cancer Research 2019.
The four Nordic EMBL Partnership Directors are featured in an article by the EMBL, discussing the benefits of collaboration and what the EMBL means to them.
Professor Janna Saarela to join the Cellular and Molecular Biology group of the Academy’s Natural Sciences Division
Research led by Irep Gözen, head of the Bionanotechnology and Membrane Systems Group, is being presented at the Biophysical Society Annual Meeting in Baltimore, USA. The findings have also been highlighted in the Norwegian national newspaper, Aftenposten
NCMM’s group leaders, Board members, stakeholders and Associate and Young Associate Investigators gathered at the Thon Hotel Opera in central Oslo for the 4thannual NCMM Network Meeting on 26 and 27 February.
NCMM congratulates NCMM Associate Investigator and Board Member, Hilde Loge Nilsen, and colleague Evandro Fei Fang on their recent research which has found that the clearance of dysfunctional mitochondria slows down the progression of Alzheimer’s Disease
The group's latest publication features in JoVE (The Journal of Visualized Experiments)
Newly appointed Director of NCMM, Professor Janna Saarela, gave a welcome talk to staff on Wednesday 9 January.
A drug development project started by the Taskén Group at NCMM is at the centre of a new and unique co-development agreement between a Norwegian start-up and an Indian pharmaceutical company.
Unlike Sweden, Denmark and Finland, Norway currently does not have a dedicated cryo electron microscopy facility for single particle analysis. We interviewed NCMM’s Acting Director, Hartmut Luecke, and researcher Eva Cunha, about their experiences with using cryo-EM and the current plans to bring the technology to Norway.
Dr Mathelier, head of the Computational Biology and Gene Regulation Group at NCMM, has been awarded a prestigious grant by the Research Council of Norway.
Congratulations to the Mathelier Group on their recent publication in the journal Nucleic Acids Research. PhD student in the Mathelier Group, Marius Gheorghe, is first author on the paper.
Sandra Lopez-Aviles and Anthony Mathelier both awarded grants as part of Norwegian Cancer Society’s annual open call.
Former NCMM Director, Professor Kjetil Taskén, features in an article about the history of patents in research, and the pros and cons associated with the practice.
The University of Oslo has recruited Dr Janna Saarela, Research Director of Institute for Molecular Medicine Finland (FIMM), the Finnish node of the Nordic EMBL Partnership, as the new Director of Centre for Molecular Medicine Norway (NCMM).